Boston Scientific stock gets boost on FDA device approval

March 17, 2015 1:57 AM

4 0

Boston Scientific stock gets boost on FDA device approval

Boston Scientific Corp.’s stock climbed nearly 4 percent Monday after the Food and Drug Administration approved a heavily studied heart device intended to cut the risk of stroke in patients with quivering hearts.

The FDA voted to allow commercial sales of the Watchman left atrial appendage closure device late Friday, following an unusually long approval process that started in 2009. The Minnesota-designed device is approved for patients whose atrial fibrillation causes a high risk of having a stroke and who ...

Read more

To category page

Loading...